HOPA President Brings Expertise and Unique Perspective to Hematology/Oncology Pharmacy Practice
Milwaukee, WI – Heidi D. Finnes, PharmD, BCOP, FHOPA became President of the Hematology/ Oncology Pharmacy Association (HOPA) on April 1, 2022 at the association’s annual conference in Boston, Massachusetts. Dr. Finnes previously served as At-Large Member on the HOPA Board of Directors from 2015 to 2019 and has volunteered on and led numerous committees and task forces.
Deep Hematology/Oncology Pharmacy Experience Dr. Finnes is Senior Manager, Pharmacy Cancer Research at the Mayo Clinic Cancer Center in Rochester, Minnesota and Assistant Professor of Pharmacy in the Mayo Clinic College of Medicine. She is actively involved in Mayo Clinic Cancer Center clinical trial review as cancer research pharmacy manager and coordinates outpatient PGY1 and PGY2 educational experiences in oncology and investigational drug services.
Dr. Finnes has worked in inpatient and outpatient hematology/oncology at Mayo Clinic since 1998. She received her Doctor of Pharmacy degree from Drake University and has been a Board Certified Oncology Pharmacist since 2003. Unique Perspective: Person with Cancer and Provider of Care Dr. Finnes was diagnosed with Stage IIB malignant melanoma in 2008 and metastatic melanoma in 2014.
Her experience with cancer treatment, including surgeries, radiation, chemotherapy, and immunotherapy give her firsthand understanding of cancer treatments. With support from the Mayo Cancer Center, Dr. Finnes identified a need for institutional recognition of the pharmacist as a critical member of the healthcare team. She helped establish and currently participates in a growing medication therapy management clinic for oncology patients and patients experiencing adverse events on immunotherapy
